These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37814519)

  • 1. Topical insulin, a novel corneal epithelial regeneration agent in dry eye disease.
    Burgos-Blasco B; Diaz-Valle D; Rego-Lorca D; Perez-Garcia P; Puebla-Garcia V; Fernandez-Vigo JI; Benitez-Del-Castillo JM; Gegundez-Fernandez JA
    Eur J Ophthalmol; 2024 May; 34(3):719-725. PubMed ID: 37814519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
    Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M
    Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
    Jirsova K; Brejchova K; Krabcova I; Filipec M; Al Fakih A; Palos M; Vesela V
    Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Insulin for Ocular Surface Disease.
    Cid-Bertomeu P; Vilaltella M; Martínez M; Mir M; Huerva V
    J Ocul Pharmacol Ther; 2024 May; 40(4):204-214. PubMed ID: 38527183
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
    Nichols JJ; Bickle KM; Zink RC; Schiewe MD; Haque RM; Nichols KK
    Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
    Lee HS; Ji YS; Yoon KC
    Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
    Hartstein I; Khwarg S; Przydryga J
    Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial.
    Chen M; Gong L; Sun X; Xie H; Zhang Y; Zou L; Qu J; Li Y; He J
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
    Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
    Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease.
    Azari AA; Karadag R; Kanavi MR; Nehls S; Barney N; Kim K; Longo W; Hematti P; Juckett M
    Cutan Ocul Toxicol; 2017 Jun; 36(2):152-156. PubMed ID: 27380960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
    Sall K; Stevenson OD; Mundorf TK; Reis BL
    Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
    Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
    Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery.
    Lekhanont K; Jongkhajornpong P; Choubtum L; Chuckpaiwong V
    Biomed Res Int; 2013; 2013():521315. PubMed ID: 23984378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease.
    Hussain M; Shtein RM; Sugar A; Soong HK; Woodward MA; DeLoss K; Mian SI
    Cornea; 2014 Dec; 33(12):1245-51. PubMed ID: 25299423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
    Davitt WF; Bloomenstein M; Christensen M; Martin AE
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic dry eye treatment with autologous platelet-rich plasma.
    Alio JL; Colecha JR; Pastor S; Rodriguez A; Artola A
    Ophthalmic Res; 2007; 39(3):124-9. PubMed ID: 17374962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.